HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The Scorpion Toxin Analogue BmKTX-D33H as a Potential Kv1.3 Channel-Selective Immunomodulator for Autoimmune Diseases.

Abstract
The Kv1.3 channel-acting scorpion toxins usually adopt the conserved anti-parallel β-sheet domain as the binding interface, but it remains challenging to discover some highly selective Kv1.3 channel-acting toxins. In this work, we investigated the pharmacological profile of the Kv1.3 channel-acting BmKTX-D33H, a structural analogue of the BmKTX scorpion toxin. Interestingly, BmKTX-D33H, with its conserved anti-parallel β-sheet domain as a Kv1.3 channel-interacting interface, exhibited more than 1000-fold selectivity towards the Kv1.3 channel as compared to other K⁺ channels (including Kv1.1, Kv1.2, Kv1.7, Kv11.1, KCa2.2, KCa2.3, and KCa3.1). As expected, BmKTX-D33H was found to inhibit the cytokine production and proliferation of both Jurkat cells and human T cells in vitro. It also significantly improved the delayed-type hypersensitivity (DTH) responses, an autoreactive T cell-mediated inflammation in rats. Amino acid sequence alignment and structural analysis strongly suggest that the "evolutionary" Gly11 residue of BmKTX-D33H interacts with the turret domain of Kv1 channels; it appears to be a pivotal amino acid residue with regard to the selectivity of BmKTX-D33H towards the Kv1.3 channel (in comparison with the highly homologous scorpion toxins). Together, our data indicate that BmKTX-D33H is a Kv1.3 channel-specific blocker. Finally, the remarkable selectivity of BmKTX-D33H highlights the great potential of evolutionary-guided peptide drug design in future studies.
AuthorsFang Ye, Youtian Hu, Weiwei Yu, Zili Xie, Jun Hu, Zhijian Cao, Wenxin Li, Yingliang Wu
JournalToxins (Toxins (Basel)) Vol. 8 Issue 4 Pg. 115 (Apr 19 2016) ISSN: 2072-6651 [Electronic] Switzerland
PMID27104568 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • CD3 Complex
  • Cytokines
  • Immunologic Factors
  • KTX toxin, Buthus
  • Kv1.3 Potassium Channel
  • Potassium Channel Blockers
  • Scorpion Venoms
  • Ovalbumin
Topics
  • Amino Acid Sequence
  • Animals
  • Autoimmune Diseases
  • CD3 Complex
  • Cell Proliferation (drug effects)
  • Cells, Cultured
  • Cytokines (metabolism)
  • Female
  • HEK293 Cells
  • Humans
  • Hypersensitivity, Delayed (chemically induced, drug therapy)
  • Immunologic Factors (chemistry, pharmacology, therapeutic use)
  • Jurkat Cells
  • Kv1.3 Potassium Channel (physiology)
  • Ovalbumin
  • Potassium Channel Blockers (chemistry, pharmacology, therapeutic use)
  • Rats, Inbred Lew
  • Scorpion Venoms (chemistry, pharmacology, therapeutic use)
  • Scorpions
  • Sequence Alignment
  • T-Lymphocytes (drug effects, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: